NSC |
Compound |
Enrichment |
Correlation |
NSC 722779 |
dabequine |
0.0490935610249067 |
-0.080395877 |
NSC 724910 |
3,12-Epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin, 10,10'-[(2-hydroxy-1,3-propanediyl)bis(oxy)] bis[decahydro- 3,6,9-trimethyl-, hemisuccinate |
0.0490935610249067 |
0.20521022 |
NSC 727012 |
(2S,3S)-3,4-Epoxy-2-(3-methoxy-5-methyl-1-naphthoyloxy)-3-methylbutanamide |
0.0490935610249067 |
0.12619856 |
NSC 727759 |
1-benzyl-3-chloro-4-(3-chloroanilino)-2,5-dihydro-1H-2,5-pyr roledione |
0.0490935610249067 |
0.36554951 |
NSC 727985 |
NSC 708781 incorporated in micelles, 0.55% (w/w) of drug |
0.0490935610249067 |
0.23133065 |
NSC 730460 |
16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-3b-py rrolidino-5-androsten-17b-YL acetate |
0.0490935610249067 |
0.34496726 |
NSC 731155 |
6-(3-Aminopropyl)-5,6-dihydro-5,11-dioxo-3-nitro-11H-indeno[ 1,2-c]isoquinoline Hydrochloride salt |
0.0490935610249067 |
0.17379036 |
NSC 745923 |
Null |
0.0490935610249067 |
0.028815965 |
NSC 747292 |
Null |
0.0490935610249067 |
0.26165298 |
NSC 75140 |
Benzenesulfonamide, 4-[(6,7-dihydro-6-thioxo-1H-purin-8-yl)azo]- |
0.0490935610249067 |
0.25619891 |